Stock Screener App

Gratuito -

Installare

20.14

2.23% 0.44

Lyell Immunopharma Inc (LYEL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Lyell Immunopharma Inc Azioni (LYEL) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	87.50% 0.015	0.008	0.007	0.011	0.034
Operating Expenses	20.96% 37.27	47.15	57.37	201.16	50.54
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	20.96% 37.27	47.15	57.37	201.16	50.54
Operating Income/Loss	20.97% -37.25	-47.14	-57.37	-201.15	-50.51
Nonoperating Income/Loss	135.75% -1.593	4.456	5.172	9.212	5.922
Income/Loss From Continuing Operations Before Tax	87.50% 0.015	0.008	0.007	0.011	0.034
Income/Loss From Continuing Operations After Tax	8.99% -38.85	-42.68	-52.20	-191.94	-44.58
Net Income/Loss	8.99% -38.85	-42.68	-52.20	-191.94	-44.58
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	23.49% 18.27	14.79	295.10	6.157	256.31
Diluted Average Shares	23.49% 18.27	14.79	295.10	6.157	256.31
Basic Earnings Per Share	26.30% -2.13	-2.89	-0.18	-0.72	-0.17
Diluted Earnings Per Share	26.30% -2.13	-2.89	-0.18	-0.72	-0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters